One potential explanation for how these observations fit together is that infection-induced insulin resistance could drive preferential utilization of lipids systemically, making glucose available for utilization by immune cells (which express higher levels of Glut-1 and consume more glucose, Figure 5). The gene discussed is SLC2A1; the disease is Insulin resistance.